Environmental Persistent Pharmaceutical Pollutants: Difference between revisions
Jump to navigation
Jump to search
(Minor Clarification) |
(Added some more links under the "Internal Links" section) |
||
| Line 8: | Line 8: | ||
=Internal Links= | =Internal Links= | ||
* | *[[Persistent Organic Pollutants]] | ||
=External Links= | =External Links= | ||
*[https://en.wikipedia.org/wiki/Environmental_persistent_pharmaceutical_pollutant The Wikipedia Page on Environmental Persistent Pharmaceutical Pollutants] | *[https://en.wikipedia.org/wiki/Environmental_persistent_pharmaceutical_pollutant The Wikipedia Page on Environmental Persistent Pharmaceutical Pollutants] | ||
*[https://www.unep.org/explore-topics/chemicals-waste/what-we-do/emerging-issues/environmentally-persistent-pharmaceutical The UNEP Page on EPPPs ] | *[https://www.unep.org/explore-topics/chemicals-waste/what-we-do/emerging-issues/environmentally-persistent-pharmaceutical The UNEP Page on EPPPs ] | ||
Revision as of 17:03, 16 July 2022
Basics
- A class of Contaminants of emerging concern
- Abbreviated as EPPP(s)
- Essentially Pharmaceutical Precursors, Pharmaceuticals, and Pharmaceutical Metabolites / Waste
- Can come from a Point Source such as a factory, but the main context is in Black Water by people utilizing Pharmaceuticals
- Various methods of Wastewater Treatment may concentrate these as well
- The Direct Impact is of concern, but synergistic effects are of special interest